$AMP

McGraw Deirdre Davey sold $1.3M of AMP

McGraw Deirdre Davey (EVP Mktg, Strat. & Comms.) sold 2,400 shares of AMERIPRISE FINANCIAL INC (AMP) at $558.28 ($1.34M total) on 2026-08-06.

Original reporting
SEC EDGAR · McGraw Deirdre Davey
Published Aug 10, 2026, 8:23 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 8:46 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AMP
Neutral
high confidence
Mentioned
$AMP
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPNeutralLow
01

Why it matters

The newest fact is the specific sale size, price, and post-transaction holdings by an EVP; it does not include any new operational or financial guidance.

02

Market read

Traders may note the insider sale, but the disclosure lacks fundamental catalysts and is typically low signal.

03

What to watch

The article does not state whether the sale was for diversification, taxes, or pre-planned liquidity needs; absence of a 10b5-1 plan does not, by itself, imply bearish information.

Relevance 6/10Novelty 3/10Timing: Filed 2026-08-10, transaction dated 2026-08-06.

Background

The article is a SEC Form 4 insider transaction disclosure for Ameriprise Financial (AMP).

Company-level read

Ticker impact

$AMPNeutralHigh confidence
Context

Ameriprise Financial (AMP) disclosed an officer open-market sale of 2,400 shares at $558.2778 on 2026-08-06 via Form 4.

Expected impact

Likely minimal near-term impact; any effect is typically sentiment-only and outweighed by normal trading noise.

Evidence & confidence

The filing is an open-market sale by an EVP, with no 10b5-1 plan and no accompanying corporate event, contract, or performance disclosure in the text.

Market effects

No sector read-through is provided; this is company-specific insider trading disclosure.

None indicated.

None indicated.

Counterpoint

Insider sales can sometimes precede negative developments, but this filing provides no such signal beyond the sale itself.

Key entities

  • AMERIPRISE FINANCIAL INC

    Subject of the Form 4 insider transaction disclosure.

  • McGraw Deirdre Davey

    EVP Mktg, Strat. & Comms. who sold 2,400 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMPMed

AMP (ASX:AMP) Is Up 12.6% After Strong Half-Year Profit Lift - What's Changed

AMP Limited reported half-year results to 30 June 2026, with revenue up to A$1,425 million and net income to A$154 million. Basic EPS from continuing operations rose to A$0.061. The article links the profit lift to efficiency and business mix changes, notes margin and cost risks, and mentions Richard Millington’s appointment to lead Employer Adviser Partnerships.

$AMPMed

AMP Shares At Highest Level In Years, Lead ASX 200 Gainers

AMP Ltd shares (ASX:AMP) rose 5.96% to A$2.31, near a 2018 high, after its half-year 2026 results. Assets under management grew 8.2% to $167.6B. Platforms net cash flows rose 33% to $3.1B, and Superannuation net inflows were $76M. Underlying NPAT rose 33% to $174M. Interim dividend was 3c (20% franked) and AMP plans a $150M buyback.

$AMPMedAI 8/10

Why is AMP stock surging today?

AMP shares rose 6% to a seven-year high of A$2.31 after the company reported a strong half-year. Underlying net profit after tax rose 33% to AUD 174 million, beating analyst consensus of about AUD 142 million and the company’s AUD 170–180 million guidance. Statutory NPAT rose 57% to AUD 154 million. AMP also announced a AUD 150 million buyback and raised its dividend payout ratio to 41% from 35%.

$AMPMed

AMP H1 profit jumps 57% on China partnerships, wealth gains

AMP Limited reported a 57% rise in half-year net profit to A$154 million for the six months ended June 30, driven by stronger China partnerships and wealth platforms that offset weaker banking. Revenue rose 4% to A$1.425 billion. Underlying profit increased 32.8% to A$174 million. The board declared a 3.0c interim dividend and approved an additional on-market buyback tranche up to A$150 million.

$AMPMed

40-year investor loan with 10 years of IO launches

AMP Bank launched “Equity Flex,” a 40-year loan for real estate investors with LVR up to 80%. It offers 6 to 10 years interest-only, with rates starting at 6.54% (60% LVR) and 6.59% (80% LVR), and fixed P&I at 6.39% p.a. The bank cites investor cash-flow needs amid higher rates and tax changes.